摘要:
Engineered non-plant cells that produce a benzylisoquinoline alkaloid product that is a derivative of canadine along a metabolic pathway that converts canadine, or an analog of canadine, to a noscapinoid product are provided. Methods of culturing engineered non-plant cells that produce a noscapinoid product and pharmaceutical compositions are also provided.
摘要:
The present invention relates to a microbial cell for producing at least one acyl amino acid, wherein the cell is genetically modified to comprise; - a first genetic mutation that enables the cell to produce at least one acyl amino acid and; - a second genetic mutation that enables the cell to decrease glutamate breakdown relative to the wild type cell.